Form 4: Amneal Pharmaceuticals President Reports Stock Transaction
Insider Transaction (Form 4)
Andrew S Boyer, Executive Vice President of Amneal Pharmaceuticals, Inc., reported a transaction in 80,000 shares of common stock on September 1, 2026.
Summary
- Bona fide gift: disposed of 80,000 Class A Common Stock on September 1, 2026; holds 193,646 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Andrew S Boyer — Officer (Executive Vice President)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Bona fide gift | Class A Common Stock | 80,000 | — | — | 193,646 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Bona fide gift (80,000 shares) |
Keywords
insider transaction, Form 4, AMRX, Amneal Pharmaceuticals, Inc., neutral, Andrew S Boyer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.